nitrites has been researched along with Fetal Growth Restriction in 9 studies
Nitrites: Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M=metal) are all insoluble, except the alkali nitrites. The organic nitrites may be isomeric, but not identical with the corresponding nitro compounds. (Grant & Hackh's Chemical Dictionary, 5th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Serum nitrites/nitrates as well as serum growth hormone levels were significantly increased by ARG, in every woman, irrespective of the presence of fetal growth retardation." | 5.08 | Effects of L-arginine on utero-placental circulation in growth-retarded fetuses. ( Facchinetti, F; Galassi, MC; Mazza, V; Neri, I; Volpe, A, 1996) |
| "02) rose with fetal growth restriction while asymmetric dimethylarginine decreased (p = 0." | 3.78 | Compensatory feto-placental upregulation of the nitric oxide system during fetal growth restriction. ( Begliuomini, S; Boldrini, A; Casarosa, E; Coceani, F; Fink, B; Genazzani, AR; Ghirri, P; Pisaneschi, S; Ripoli, A; Sanchez, AM; Simoncini, T; Strigini, FA, 2012) |
| "In both rat strains Suramin caused fetal growth retardation, decreased placental blood flow, and increased placental concentration of the isoprostane 8-iso-PGF(2alpha)." | 3.73 | Placental dysfunction in Suramin-treated rats: impact of maternal diabetes and effects of antioxidative treatment. ( Eriksson, UJ; Nash, P; Olovsson, M, 2005) |
| "Research on the pathogenesis of preeclampsia in several studies has established the involvement of the NO-system in preeclampsia and fetal intrauterine growth restriction (IUGR)." | 1.33 | Plasma- and urine concentrations of nitrite/nitrate and cyclic Guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies. ( Bidlingmaier, M; Friese, K; Jeschke, U; Kainer, F; Mylonas, I; Schiessl, B; Strasburger, C, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Travis, OK | 1 |
| Baik, C | 1 |
| Tardo, GA | 1 |
| Amaral, L | 1 |
| Jackson, C | 1 |
| Greer, M | 1 |
| Giachelli, C | 1 |
| Ibrahim, T | 1 |
| Herrock, OT | 1 |
| Williams, JM | 1 |
| Cornelius, DC | 1 |
| Tropea, T | 1 |
| Nihlen, C | 1 |
| Weitzberg, E | 1 |
| Lundberg, JO | 1 |
| Wareing, M | 1 |
| Greenwood, SL | 1 |
| Sibley, CP | 1 |
| Cottrell, EC | 1 |
| Tsikas, D | 1 |
| Bollenbach, A | 1 |
| Savvidou, MD | 1 |
| Pisaneschi, S | 1 |
| Strigini, FA | 1 |
| Sanchez, AM | 1 |
| Begliuomini, S | 1 |
| Casarosa, E | 1 |
| Ripoli, A | 1 |
| Ghirri, P | 1 |
| Boldrini, A | 1 |
| Fink, B | 1 |
| Genazzani, AR | 1 |
| Coceani, F | 1 |
| Simoncini, T | 1 |
| Nash, P | 1 |
| Olovsson, M | 1 |
| Eriksson, UJ | 1 |
| Schiessl, B | 1 |
| Strasburger, C | 1 |
| Bidlingmaier, M | 1 |
| Mylonas, I | 1 |
| Jeschke, U | 1 |
| Kainer, F | 1 |
| Friese, K | 1 |
| Sooranna, SR | 1 |
| Das, I | 1 |
| Neri, I | 1 |
| Mazza, V | 1 |
| Galassi, MC | 1 |
| Volpe, A | 1 |
| Facchinetti, F | 1 |
| Greenberg, SS | 1 |
| Lancaster, JR | 1 |
| Xie, J | 1 |
| Sarphie, TG | 1 |
| Zhao, X | 1 |
| Hua, L | 1 |
| Freeman, T | 1 |
| Kapusta, DR | 1 |
| Giles, TD | 1 |
| Powers, DR | 1 |
1 trial available for nitrites and Fetal Growth Restriction
| Article | Year |
|---|---|
Effects of L-arginine on utero-placental circulation in growth-retarded fetuses.
Topics: Adult; Arginine; Blood Flow Velocity; Female; Fetal Growth Retardation; Humans; Infusions, Parentera | 1996 |
8 other studies available for nitrites and Fetal Growth Restriction
| Article | Year |
|---|---|
Adoptive transfer of placental ischemia-stimulated natural killer cells causes a preeclampsia-like phenotype in pregnant rats.
Topics: Adoptive Transfer; Animals; Cyclic GMP; Cytokines; Female; Fetal Growth Retardation; Ischemia; Kille | 2021 |
Enhanced Nitrite-Mediated Relaxation of Placental Blood Vessels Exposed to Hypoxia Is Preserved in Pregnancies Complicated by Fetal Growth Restriction.
Topics: Chorion; Female; Fetal Growth Retardation; Fetus; Humans; Hypoxia; Myography; Nitric Oxide; Nitrites | 2021 |
Inverse correlation between maternal plasma asymmetric dimethylarginine (ADMA) and birthweight percentile in women with impaired placental perfusion: circulating ADMA as an NO-independent indicator of fetal growth restriction?
Topics: Adult; Arginine; Biomarkers; Birth Weight; Female; Fetal Growth Retardation; Fetus; Gestational Age; | 2018 |
Compensatory feto-placental upregulation of the nitric oxide system during fetal growth restriction.
Topics: Adaptation, Physiological; Adult; Arginine; Endothelial Cells; Endothelium, Vascular; Female; Fetal | 2012 |
Placental dysfunction in Suramin-treated rats: impact of maternal diabetes and effects of antioxidative treatment.
Topics: Animals; Antioxidants; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Electrolytes; E | 2005 |
Plasma- and urine concentrations of nitrite/nitrate and cyclic Guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies.
Topics: Birth Weight; Cyclic GMP; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Nitrates; Nitri | 2006 |
The inter-relationship between polyamines and the L-arginine nitric oxide pathway in the human placenta.
Topics: Amino Acid Oxidoreductases; Arginine; Cadaverine; Cell Line; Chorionic Villi; Female; Fetal Growth R | 1995 |
Effects of NO synthase inhibitors, arginine-deficient diet, and amiloride in pregnant rats.
Topics: Abnormalities, Drug-Induced; Amiloride; Analysis of Variance; Animals; Arginine; Female; Fetal Death | 1997 |